This humanized monoclonal antibody against VEGF, is approved in combination with chemotherapy for treating many types of advanced cancer, including colorectal cancer, non–small cell lung cancer, breast cancer, renal cell carcinoma, and glioblastoma multiforme [31, 32]. This evidence concerns the gene VEGFA and cancer.